Completed NA INTERVENTIONAL 2-arm NCT01126099

Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease

Sponsor: National Institute on Aging (NIA)

Updated 8 times since 2017 Last updated: May 19, 2015 Started: Mar 31, 2010 Primary completion: Mar 31, 2014 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Alzheimer's Disease, this trial is completed. The trial is conducted by National Institute on Aging (NIA) and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Mar 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Aging (NIA)
Seattle Institute for Biomedical and Clinical Research
VA Puget Sound Health Care System

Data source: Seattle Institute for Biomedical and Clinical Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States